Opening soon—Ages 18 Years and up

Registry of Minimally Invasive Cancer Treatment Using Spectral Angio-CT Image Guidance

Sponsor: Mark C Burgmans, MD PhD · NCT07636148 on ClinicalTrials.gov ↗

Conditions studied

Liver Cancer (Primary and Metastatic)Lung Cancer (Diagnosis)Bone Cancer MetastaticBone Cancer TumorKidney TumorsRenal CancerHepatocellular Carcinoma (HCC)Renal Cell Carcinoma (Kidney Cancer)Renal Cell Carcinoma (RCC)Musculoskeletal CancersMusculoskeletal TumorsBone TumorsLung Tumors

Where it's running3 sites

3 international sites

Hospices Civils de Lyon - Hôpital Édouard Herriot
Lyon, Auvergne-Rhône-Alpes, France 69002
- Prof. Dr. Laurent Milot(contact)[email protected]
- Prof. Dr. Laurent Milot(principal investigator)
Assistance Publique Hopitaux de Paris - Hôpital Henri Mondor
Créteil, Île-de-France Region, France 94000
- Prof Dr. Hicham Kobeiter(contact)[email protected]
- Prof Dr. Hicham Kobeiter(principal investigator)
Leiden University Medical Center
Leiden, South Holland, Netherlands 2333 ZA
- Emma C.M. Buijsman, MSc(contact)+ 31 71 526 49 50 [email protected]
- Prof. Dr. Mark C. Burgmans(principal investigator)
- Dr. Ir. Jouke Dijkstra(sub investigator)

See the official eligibility language

Shown exactly as written on ClinicalTrials.gov. Your oncologist is the right person to judge whether it fits your situation.

Inclusion Criteria:

* Age ≥ 18 years;
* Undergoing a clinically indicated IO procedure with a percutaneous or transarterial approach for solid tumors;
* Use of spectral angio-CT image guidance as part of standard care;
* Written confirmed consent.

Exclusion Criteria:

* Patients who are declared incapacitated;
* Patients suffering from psychic disorders that make a comprehensive judgement impossible.

Updated 2026-06-09 on ClinicalTrials.gov. Always confirm current details with the study team or your oncologist.